MiNK Therapeutics (INKT) Misses Q3 EPS by 65c
Tweet
Share
E-mailGet Alerts INKT Hot Sheet
Join SI Premium – FREE
MiNK Therapeutics (NASDAQ: INKT) reported Q3 EPS of ($0.65).
For earnings history and earnings-related data on MiNK Therapeutics (INKT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Weighs Tapping Musk For Equity Investment - Semafor
- Interactive Strength reports record Q2 results, raises Q3 guidance
- General Mills (GIS) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
